v3.26.1
Stockholders’ Equity (Deficit) (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 29, 2026
Jun. 26, 2026
Jun. 02, 2026
May 20, 2026
Apr. 30, 2026
Apr. 02, 2026
Oct. 24, 2025
Jun. 03, 2024
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Common stock, shares authorized                 500,000,000     500,000,000   125,000,000
Preferred stock, shares authorized                 5,000,000     5,000,000   5,000,000
Common stock, shares issued                 664,670     664,670   459,286
Common stock, shares outstanding                 664,670     664,670   459,286
Preferred stock, shares issued                      
Preferred stock, shares outstanding                      
Sale of shares of common stock   213,333                       267
Sale of Stock, Price Per Share                 $ 36.34     $ 36.34    
Aggregate proceeds share issuance                           $ 22,251
Proceeds before offering expenses                       $ 1,860,000  
Share based compensation arrangement description                       On June 5, 2026, the Company entered into Amendment No. 3 to Alison Silva’s employment agreement, appointing Ms. Silva as Chief Operating Officer and President and increasing her base salary to $340,200 from $315,000. In connection with the amendment, on June 2, 2026, the Board approved a one-time option grant to Ms. Silva to purchase up to 8,000 shares of common stock under the 2025 Equity Incentive Plan, vesting over three years commencing September 2, 2026 in equal quarterly installments.    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period     2,666                 9,000    
Description of terms of share based payment arrangement On June 29, 2026, in connection with his appointment to the Board of Directors, the Company granted Tomas J. Philipson, Ph.D. options to purchase an aggregate of 7,152 shares of common stock under the 2025 Equity Incentive Plan. The grants consisted of (i) an option to purchase 1,200 shares in connection with his appointment and (ii) an option to purchase 5,952 shares in lieu of the annual cash retainer and committee fees otherwise payable for his service on the Board and its committees.                          
Fair value of consideration for services                   $ 46,750 $ 66,000 $ 46,750    
Issued of aggregate fair value shares         1,333                  
Number of restricted shares issued, value                        
Number of stock purchase                 64,000     77,279    
Compensation expense for services                 $ 380,183   $ 380,183      
Exercise price                 $ 65.33     $ 65.33   $ 77.56
Vested, term                       6 years 7 months 6 days   5 years 4 months 24 days
Share-Based Payment Arrangement, Expense                       $ 991,989    
Compensation Expense, Excluding Cost of Good and Service Sold                       945,239    
Salary and Wage, Officer, Excluding Cost of Good and Service Sold                       $ 46,750    
Percentage of restricted stock units vested on grant date         25.00%                  
Shares outstanding                 1,333     1,333    
Vested shares                       333    
Unvested shares                 1,000     1,000    
Unrecognized stock-based compensation                 $ 1,681,992     $ 1,681,992    
Recognized over a period                       2 years 7 months 6 days    
Two Consultants [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Stock option granted           2,666                
Exercise price           $ 27.75                
Fair value of grant date           $ 73,982                
Vested, term           10 years                
Stock options vest percentage           25.00%                
Option vested           2,000                
Office Employees [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Stock option granted     46,690                      
Exercise price     $ 20.85                      
Fair value of grant date     $ 973,487                      
Vested, term     10 years                      
Stock options vest percentage     25.00%                      
Director [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Stock option granted 7,152                          
Exercise price $ 21.00                          
Fair value of grant date $ 150,192                          
Vested, term 10 years                          
2025 Equity Incentive Plan [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period     28,820                      
Convertible Note One [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Sale of shares of common stock                       77,546    
Net proceeds                       $ 2,937,948    
2025 Convertible Notes [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Debt Conversion, Converted Instrument, Shares Issued                       1,519    
Common Stock [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Director purchase, shares     1,333                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period                   9,000        
Shares issued for services                   667 1,376 667    
Fair value of consideration for services                        
Issued of aggregate fair value shares                 21,680   21,680      
Number of restricted shares issued, value                 $ 2   $ 2      
Common Stock [Member] | IPO [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Aggregate proceeds share issuance               $ 150,000            
Issued of aggregate fair value shares               46,500            
Number of restricted shares issued, value               $ 4,638,375            
Number of stock purchase               500            
Share purchase price               $ 99.75            
Common Stock [Member] | IPO [Member] | Entity Three [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Issued of aggregate fair value shares               15,500            
Securities Purchase Agreement [Member] | Common Stock [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Sale of shares of common stock       95,238                    
Sale of Stock, Price Per Share       $ 21.00                    
Aggregate proceeds share issuance       $ 2,000,000.0                    
Placement agent fees       140,000                    
Proceeds before offering expenses       $ 1,860,000                    
Standby Equity Purchase Agreement [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Net proceeds                           $ 5,100,000
Standby Equity Purchase Agreement [Member] | Maximum [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Aggregate proceeds share issuance             $ 20,000,000.0